“…Signaling by NTRK1 (TRKA) [55], cardiac conduction [56], signaling by GPCR [57], immune system [58], cytokine signaling in immune system [59], interferon signaling [60] and toll-like receptor cascades [61] were responsible for development of PD. Recent studies have shown that EGR2 [62], WNT1 [63], ARC (activity regulated cytoskeleton associated protein) [64], CHRNA7 [65], SEZ6L2 [66], IL1RAPL2 [67], PER2 [68], PCDH19 [69], CNTNAP2 [70], SLC12A5 [71], CDK5 [72], ACTL6B [73], GABRD (gamma-aminobutyric acid type A receptor subunit delta) [74], CACNA1G [75], HTR2C [76], STX1A [77], ATP1A3 [78], RIMS3 [79], CNTNAP2 [80], CDH8 [81], SCAMP5 [82], SYNGR1 [83], ARHGEF9 [84], DLG3 [85], RBP4 [86], IL9 [87], S100A9 [88], HGF (hepatocyte growth factor) [89], C3 [90], FKBP5 [91], GABRE (gamma-aminobutyric acid type A receptor subunit epsilon) [92], NCKAP1L [93], PIK3CG [94], ITGB3 [95], ANXA1 [96], SYNE2 [97] and DBI (diazepam binding inhibitor, acyl-CoA binding protein) [98] were closely involved with the occurrence, development, and prognosis of autism spectrum disorder. EGR2 [99], ADCYAP1 [100], CHRNA7 [101], NRN1 [102], ETV5 [103], STXBP1 [104], CAMKK2 [105], VAMP2 [106], SYNGR1 [107], NOD2 [108], TLR2 [109], BRCA2 [110] and LEF1 [111] were previously reported to be critical for the development of bipolar disorder.…”